Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
b decrease » _ decrease (Expand Search), b1 decreased (Expand Search), _ decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
b decrease » _ decrease (Expand Search), b1 decreased (Expand Search), _ decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1281
-
1282
-
1283
-
1284
-
1285
Retinoic acid decreases ATF-2 phosphorylation and sensitizes melanoma cells to taxol-mediated growth inhibition-0
Published 2011“…A cells. B16 cells and Melan-a cells were harvested at 80% confluence, and cytoplasmic and nuclear protein were isolated using Pierce NE-PER™ nuclear and cytoplasmic extraction reagents described in Materials and Methods. …”
-
1286
Retinoic acid decreases ATF-2 phosphorylation and sensitizes melanoma cells to taxol-mediated growth inhibition-5
Published 2011“…A cells. B16 cells and Melan-a cells were harvested at 80% confluence, and cytoplasmic and nuclear protein were isolated using Pierce NE-PER™ nuclear and cytoplasmic extraction reagents described in Materials and Methods. …”
-
1287
-
1288
-
1289
-
1290
-
1291
-
1292
-
1293
-
1294
-
1295
-
1296
6-OHDA-treated monkeys have decreased PGP9.5-ir in cardiac nerve bundles and fibers.
Published 2014“…Within the 6-OHDA group there was a significant reduction in ratio between walls (ANOVA; F(3,16) = 3.299, <i>P</i> = 0.047) with significant loss in the inferior compared to septal wall (<sup>b</sup><i>P</i> = 0.044). …”
-
1297
-
1298
Decreased antihyperglycemic drug use driven by high out-of-pocket costs despite Medicare coverage gap closure
Published 2020“…<a><b>Objectives</b></a>: <a>Using the 2016 Medicare part D coverage gap as an example, we explored effects of increased out-of-pocket costs on adherence to branded </a>dipeptidyl peptidase-4 inhibitors (DPP-4i) in patients without financial subsidies, relative to subsidized patients who do not experience increased spending during the gap. …”
-
1299
-
1300